大熊猫犬冠状病毒部分S基因的克隆与全S基因序列分析

从重庆某动物园死亡的大熊猫肝脏中分离到一株病毒，经鉴定为犬冠状病毒（命名为CCV DXMV）。本实验根据CCV K378和CCV Insavc-1株基因序列设计合成了普通PCR引物SF1-SR1和SF2-SR2，以及半套式引物SF3-SR3、SR13、SF13、SF4-SR4和SF14，分段扩增了CCVDXMV株部分S基因，得到了368bp、792bp、737bp、1178bp和985bp5个基因片段。将纯化的RCR产物分别克隆到pGEM—T载体中，通过筛选和鉴定，获得了5个阳性重组质粒。将重组质粒送生物公司测序，将测得的基因序列与先前测定的该株病毒部分S基因序列，拼接成全S基因序列，并与其它株CCV及TGEV HN2002和FIPV79—1146株的S基因序列进行分析比较，绘制进化树。结果表明，该株病毒与CCV K378株的同源性最高，达到99．4％；而与CCV 23／03株的同源性最低，为56．9％；与FIPV和TGEV分别有90．4％和82．1％的同源性。     

水貂奇异变形杆菌的分离与鉴定

2005年7月,辽宁省某水貂养殖场出现了以零星散发、高死亡率和多种内脏器官出现出血性败血症为主要流行病学特点的病例。从病死水貂内脏中分离出1株细菌,经染色、镜检和生化试验鉴定为奇异变形杆菌。应用药敏试验筛选出了高度敏感的抗菌药,控制了该病的继续发生。     

1株高致病性血凝性脑脊髓炎病毒的分离与鉴定

利用细胞培养方法从临床表现神经症状的死亡仔猪脑组织内分离获得1株病毒,同时对该病毒进行电镜负染观察、昆明种小鼠致病性试验、RT-PCR检测和部分基因测序分析。电镜观察可见细胞培养物中有大量的直径约115 nm的冠状病毒样粒子;接种病毒的小鼠均出现典型的神经症状,死亡率100%;血凝性脑脊髓炎病毒(HEV)特异性引物RT-PCR扩增结果阳性;其S基因序列与GenBank中登录的HEV-67 N相应基因序列的同源性高达99.6%。结果表明,分离的病毒为猪血凝性脑脊髓炎病毒,分离株暂命名为HEV-CC-2007。     

鸡肾型传染性支气管炎病毒的分离鉴定

从安徽省巢湖地区鸡群中出现的以肾肿大为主要特征的呼吸道疾病的病例中分离到1株病毒,易感雏鸡,病死鸡出现肾肿大、苍白呈花斑状、大量尿酸盐沉积;鸡胚连续盲传至第5代时开始出现死亡和侏儒胚.电镜观察可见80～120nm的病毒颗粒.分离病毒在鸡胚上可干扰新城疫病毒clone-30株的增殖.上述试验证实所分离的病毒为鸡肾型传染性支气管炎病毒,暂定名为NIBV-AH99.     

In vitro culture, serologic and molecular analysis of Acanthamoeba isolated from the liver of a keel-billed toucan (Ramphastos sulfuratus)

Members of the genus Acanthamoeba are usually free-living amebae and are found in a variety of ecological niches including soil, fresh and brackish water, dust in air, filters of heating, ventilating, and air conditioning units, swimming pools and hot tubs, etc. Occasionally, they are also known to cause central nervous system infections in humans and other animals. We isolated into culture an amoeba from the liver tissue of a keel-billed toucan and identified it as Acanthamoeba sp. based on culture characteristics and immunofluorescent analysis. Further, we characterized the cultured amoeba and also the amoeba in the liver tissue as Acanthamoeba, genotype T4, by sequencing a diagnostic region of the nuclear small subunit ribosomal RNA gene.     

羊布鲁菌16MOmp25真核表达载体的构建

利用聚合酶链式反应（PCR）,以羊布鲁菌16M基因组为模板克隆Omp25基因,设计含有EcoRI和xhoI酶切位点的引物序列,定向克隆到真核表达载体pCMV-HA上,构建真核表达重组质粒pCMV-HA～Omp25。经测序及双酶切验证正确,证明成功构建了pCMV-HA—Omp25真核表达质粒,为表达纯化外膜蛋白Omp25,研究其功能奠定基础。     

东北虎（Panthera tigris altaica）个体识别技术研究进展

对东北虎种群的科学监测是采取有效保护、管理及恢复措施的基础,而准确的个体识别又是保证有效监测的前提。尤其是在中国,在野生东北虎种群数量很少,种群密度极低的情况下,能根据它留下的各种信息进行个体识别就显得尤为重要。目前,用于野生东北虎个体识别的技术主要有：足迹识别、DNA识别、条纹识别以及气味识别等。本文对这几种技术的特点、研究进展、应用注意事项等做了介绍,并且结合中国的实际情况,分析每种技术在中国的适用性,认为如果要建立中国的东北虎种群数量数据库,足迹识别和DNA识别比较适合在中国现有东北虎分布区推广使用。通过足迹识别,信息容易获取,也是最经济和比较成熟的方法;由于种群密度低,含DNA的遗传样本虽不能每次都采集到,但可以长期积累;现阶段条纹和气味识别只能起到辅助的作用。     

烯效唑(S3307)对湖南稷子整株水平Na+、K+选择性和游离脯氨酸分配的影响

采用盆栽试验,观察测定了烯效唑(S3307)对湖南稷子抗盐性及整株水平Na 、K 选择性和游离脯氨酸分配的影响。结果表明,喷施S3307能显著提高湖南稷子根系的Na 、K 选择性吸收能力;由叶鞘向叶片、特别是由根系向叶鞘的选择性运输能力大大提高,因而进入植物体内的Na 减少、K 增多,尤以重要光合器官表现突出。但S3307处理后,湖南稷子重要光合器官中游离脯氨酸含量并未升高。     

Successful drug development despite adverse preclinical findings part 1: processes to address issues and most important findings

Unexpected adverse preclinical findings (APFs) are not infrequently encountered during drug development. Such APFs can be functional disturbances such as QT prolongation, morphological toxicity or carcinogenicity. The latter is of particular concern in conjunction with equivocal genotoxicity results. The toxicologic pathologist plays an important role in recognizing these effects, in helping to characterize them, to evaluate their risk for man, and in proposing measures to mitigate the risk particularly in early clinical trials. A careful scientific evaluation is crucial while termination of the development of a potentially useful drug must be avoided. This first part of the review discusses processes to address unexpected APFs and provides an overview over typical APFs in particular classes of drugs. If the mode of action (MoA) by which a drug candidate produces an APF is known, this supports evaluation of its relevance for humans. Tailor-made mechanistic studies, when needed, must be planned carefully to test one or several hypotheses regarding the potential MoA and to provide further data for risk evaluation. Safety considerations are based on exposure at no-observed-adverse-effect levels (NOAEL) of the most sensitive and relevant animal species and guide dose escalation in clinical trials. The availability of early markers of toxicity for monitoring of humans adds further safety to clinical studies. Risk evaluation is concluded by a weight of evidence analysis (WoE) with an array of parameters including drug use, medical need and alternatives on the market. In the second part of this review relevant examples of APFs will be discussed in more detail.     

鸭疫里默氏菌的分离鉴定及免疫原性

自西安某鸭场病鸭中分离到 1株菌 ,经染色镜检、分离培养、生化试验、动物回归试验 ,鉴定为鸭疫里默氏菌 ;用分离菌株制作成油佐剂灭活疫苗 ,免疫 10日龄雏鸭 ,于免疫后 30 d用同源菌攻击 ,保护率为 83%(5 / 6 ) ,结果表明 ,本菌具有良好的免疫原性。